Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shareholders to Get $0.24 Quarterly Dividend

Key Points

• Zimmer Biomet declared a quarterly dividend of $0.24 per share, payable October 30 to shareholders of record on September 30. The dividend equates to $0.96 annually and a 1.1% yield.
• The dividend appears well covered, with an 11.5% current payout ratio and an expected future payout ratio of 10.7% based on projected earnings.
• Zimmer Biomet exceeded quarterly earnings and revenue expectations, reporting $2.07 in EPS and $2.18 billion in revenue, while analysts maintain a consensus “Hold” rating and a $103 price target.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Get Free Report) declared a quarterly dividend on Friday, August 28th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.24 per share by the medical equipment provider on Friday, October 30th. This represents a $0.96 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th.

Zimmer Biomet has a payout ratio of 11.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Zimmer Biomet to earn $8.99 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 10.7%.

Zimmer Biomet Stock Performance

Shares of ZBH opened at $91.08 on Monday. Zimmer Biomet has a 52-week low of $79.12 and a 52-week high of $106.88. The stock's 50-day simple moving average is $96.23 and its 200 day simple moving average is $91.25. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.94 and a current ratio of 1.69. The stock has a market capitalization of $17.37 billion, a price-to-earnings ratio of 22.16, a price-to-earnings-growth ratio of 1.72 and a beta of 0.47.

Zimmer Biomet (NYSE:ZBH - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.06. Zimmer Biomet had a return on equity of 13.12% and a net margin of 9.48%.The firm had revenue of $2.18 billion for the quarter, compared to analysts' expectations of $2.13 billion. During the same period in the prior year, the business posted $2.07 earnings per share. The company's revenue was up 4.8% on a year-over-year basis. Zimmer Biomet has set its FY 2026 guidance at 8.470-8.590 EPS. Research analysts forecast that Zimmer Biomet will post 8.54 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ZBH shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Zimmer Biomet in a report on Wednesday, August 5th. Wall Street Zen downgraded shares of Zimmer Biomet from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Stifel Nicolaus boosted their price target on shares of Zimmer Biomet from $105.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Truist Financial upped their price target on shares of Zimmer Biomet from $92.00 to $106.00 and gave the stock a "hold" rating in a report on Thursday, August 6th. Finally, Weiss Ratings upgraded Zimmer Biomet from a "hold (c-)" rating to a "hold (c)" rating in a research report on Monday, September 14th. Six equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $103.00.

Zimmer Biomet Company Profile

Zimmer Biomet Holdings, Inc NYSE: ZBH is a medical technology company that develops, manufactures and markets products designed to treat musculoskeletal conditions. Its portfolio includes orthopedic implants and related systems for hip, knee, shoulder and other joint replacements, as well as products used in sports medicine, extremity care and trauma procedures.

The company also provides robotic- and computer-assisted surgical technologies, digital solutions and other tools intended to support orthopedic procedures and patient care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.